Evotec SE
EVT
ISIN DE0005664809 / Valor 505433
Evotec SE
UMushroom community rating:
About company
Evotec SE is a global drug discovery and development partnership company headquartered in Germany, specializing in providing integrated solutions to the pharmaceutical and biotechnology industries. The company leverages its extensive expertise in areas such as medicinal chemistry, biology, and data science to support the development of new therapeutics across various therapeutic areas, including neuroscience, oncology, and metabolic diseases. Evotec collaborates with a diverse range of partners, including major pharmaceutical companies, biotech firms, and academic institutions, to advance innovative drug candidates from early discovery through clinical development. In the first quarter of 2025, Evotec reported progress in strategic partnerships and the implementation of initiatives aimed at achieving sustainable and profitable growth, reinforcing its position as a key player in the biopharmaceutical landscape.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
1432 M
Market cap (USD)
611,870
Daily traded volume (Shares)
8.73 / 8.45
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Meret Jaggi
Oliver Moon
Atanas WI Atanasov
EQUITIES OF THE SAME SECTOR
